ShadowBuys

NeoGenomics (NEO)

Healthcare · Medical - Diagnostics & Research

1 member of Congress has disclosed 2 trades in NeoGenomics (NEO) since 2025: 2 buys and 0 sales. The most recent was disclosed on Sep 10, 2026.

Trades disclosed
2
Members trading
1
Buys / sells
2 / 0
Reported value
$2K–$30K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow NEO

What else is happening at NEO

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. NEOFinancial report·SEC EDGAR

    NEO: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 28, 2026, 4:11 PM EDTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. NEOCompany announcement·SEC EDGAR

    NEO: Financial results

    Filed 8-K for an event or period dated 2026-10-28. Financial results.

    Public: Oct 28, 2026, 4:06 PM EDTEvent / period: Oct 28, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. NEOCompany announcement·SEC EDGAR

    NEO: Financial results · Leadership change

    Filed 8-K for an event or period dated 2026-10-05. Financial results; Leadership change.

    Public: Oct 5, 2026, 4:08 PM EDTEvent / period: Oct 5, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Who traded NEO

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.